Date: Anytime
Format: All results
Viewing results
71 -
80 of
71
-
Annals of Hematology Jun 2002
Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-11; Recombinant Proteins; Thrombocytopenia
PubMed: 12141272
DOI: 10.1007/s00277-002-0459-2